UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?

Engelhardt, M; Yong, K; Bringhen, S; Waesch, R; (2019) Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update? [Editorial comment]. Haematologica , 104 (11) pp. 2128-2131. 10.3324/haematol.2019.228684. Green open access

[thumbnail of 2128.full.pdf]
Preview
Text
2128.full.pdf - Published Version

Download (170kB) | Preview
Type: Article
Title: Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?
Open access status: An open access version is available from UCL Discovery
DOI: 10.3324/haematol.2019.228684
Publisher version: https://doi.org/10.3324/haematol.2019.228684
Language: English
Additional information: This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: https://discovery.ucl.ac.uk/id/eprint/10092313
Downloads since deposit
26Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item